Educational Videos

EDUCATIONAL OBJECTIVES
After completing this activity, the learner will:

• Gain insights from the global registries on COVID-19 in patients with RMD

• Understand treatment guidelines for patients with RMD in the context of COVID-19

• Understand the considerations for COVID vaccination in RMD and potential effects of different therapies on vaccine response

• Consider how patient management changes employed during pandemic may affect their management going forward

TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved in treating patients with inflammatory disease.

PROGRAMME OVERVIEW
Join us at the Cytokine Signalling Forum’s symposium at the EULAR 2021 annual conference. Here our expert faculty will review the most recent findings and advice on the management of patients during the COVID-19 pandemic. We will also discuss the changes in patient management, specifically focusing on the increased utilisation of telemedicine.

In this activity, Management of Rheumatic Musculoskeletal Diseases in the COVID-19 Era , international experts will discuss COVID-19 registries, key treatment guidelines, and vaccinations in the management of rheumatic musculoskeletal diseases.

INSTRUCTIONS FOR PARTICIPATION
Participants must 1) read the activity information; 2) study the educational activity; 3) successfully complete the post-module assessments with a score of 80% or better; 4) and complete the evaluation form. Upon completion of the full activity, your certificate will be made available to download and print.

DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.